One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Machine Learning-based Characterization of Longitudinal Health Care Utilization Among Patients With Inflammatory Bowel DiseasesÂ
Berkeley N Limketkai, MD, PhD, Laura Maas, MD, Mahesh Krishna, BA, Anoushka Dua, MD, Lauren DeDecker, MD, Jenny S Sauk, MD, Alyssa M Parian, MD
doi : 10.1093/ibd/izad127
Volume 30, Issue 5, May 2024
Vedolizumab Efficacy Is Associated With Decreased Intracolonic Dendritic Cells, Not Memory T CellsÂ
Elisa K Boden, MD, Ramya Kongala, Duncan C Hindmarch, Donna M Shows, Julius G Juarez, PhD, James D Lord, MD, PhD
doi : 10.1093/ibd/izad224
Estimated Glomerular Filtration Rate and the Risk of Inflammatory Bowel Disease in Adults: A Swedish Population-Based StudyÂ
Yuanhang Yang, MD, MSc, Jonas F Ludvigsson, MD, PhD, Ola Olén, MD, PhD, Arvid Sjölander, PhD, Juan J Carrero, PhD
doi : 10.1093/ibd/izac267
Appropriate Preconception Corticosteroid-Free Remission Period in Pregnant Women With Ulcerative Colitis
Aya Ikeda, MD, Reiko Kunisaki, MD, PhD, Shigeru Aoki, MD, PhD, Katsuki Yaguchi, MD, Akira Madarame, MD, Masafumi Nishio, MD, PhD, Tsuyoshi Ogashiwa, MD, Yoshinori Nakamori, MD, Hideaki Kimura, MD, PhD, Ryoichi Suzuki, MD, PhD, Yusuke Saigusa, PhD, Shin Maeda, MD, PhD
doi : 10.1093/ibd/izac270
Controlled Hookworm Infection for Medication-free Maintenance in Patients with Ulcerative Colitis: A Pilot, Double-blind, Randomized Control TrialÂ
Thomas C Mules, MBChB, Brittany Lavender, MBMedSc, Kate Maclean, BMLSc, Francesco Vacca, PhD, Sophia-Louise Noble, BSc (Hons), Bibek Yumnam, PhD, Tama Te Kawa, BSc, Alissa Cait, PhD, Jeffry Tang, PhD, David O’Sullivan, PhD, Olivier Gasser, PhD, James Stanley, PhD, Graham Le Gros, PhD, Mali Camberis, BSc (Hons), Stephen Inns, MD
doi : 10.1093/ibd/izad110
Real-World Effectiveness of Vedolizumab vs Anti-TNF in Biologic-naïve Crohn’s Disease Patients: A 2-year Propensity-score-adjusted Analysis from the VEDOIBD-Study
Bernd Bokemeyer, MD, Sandra Plachta-Danielzik, PhD, Romina di Giuseppe, PhD, Philipp Efken, MD, Wolfgang Mohl, MD, Martin Hoffstadt, MD, Thomas Krause, MD, Axel Schweitzer, MD, Elisabeth Schnoy, MD, Raja Atreya, MD, Niels Teich, MD, Leo Trentmann, MD, Robert Ehehalt, MD, Petra Hartmann, Stefan Schreiber, MD
doi : 10.1093/ibd/izad138
NAFLD Is Associated With Quiescent Rather Than Active Crohn’s Disease
Scott McHenry, MD, MSc, Matthew Glover, MD, Ali Ahmed, MD, Quazim Alayo, MD, MSc, Maria Zulfiqar, MD, Daniel R Ludwig, MD, Matthew A Ciorba, MD, Nicholas O Davidson, MD, DSc, Parakkal Deepak, MBBS, MSc
doi : 10.1093/ibd/izad129
Real-Life Efficacy of Tofacitinib in Various Situations in Ulcerative Colitis: A Retrospective Worldwide Multicenter Collaborative StudyÂ
Tamás Resál, MD, Péter Bacsur, MD, Csilla Keresztes, PhD, Anita Bálint, MD, PhD, Renáta Bor, MD, PhD, Anna Fábián, MD, PhD, Bernadett Farkas, MD, Kostas Katsanos, MD, DSc, George Michalopoylos, MD, PhD, Davide Giuseppe Ribaldone, MD, DSc, Mohamed Attauabi, MD, Mirabella Zhao, MD, PhD, Hadar Amir Barak, MD, Henit Yanai, MD, MBA, Cristina Bezzio, MD, PhD, Antonio Rispo, MD, DSc, Fabiana Castiglione, MD, DSc, Ariella Bar-Gil Shitrit, MD, DSc, Daniela Pugliese, MD, PhD, Alessandro Armuzzi, MD, PhD, Edoardo Vincenzo Savarino, MD, PhD, Martin Kolar, MD, PhD, Milan Lukáš, MD, DSc, Elena Chashkova, MD, PhD, RafaÅ‚ Filip, MD, DSc, Aurore Rozieres, PhD, Stéphane Nancey, MD, PhD, Željko Krznarić, MD, PhD, Eszter Schäfer, MD, Tamás Szamosi, MD, PhD, PatrÃcia Sarlós, MD, PhD, Matej Franko, MD, David Drobne, MD, DSc, Oleg V Knyazev, MD, Anna V Kagramanova, MD, DSc, Jimmy Limdi, MD, DSc, Panu Wetwittayakhlang, MD, Peter L Lakatos, MD, DSc, Nitsan Maharshak, MD, DSc, Lian Bannon, MD, Tibor Nyári, PhD, DSc, Zoltán Szepes, MD, PhD, Klaudia Farkas, MD, PhD, TFB Study Group, Tamás Molnár, MD, DSc
doi : 10.1093/ibd/izad135
Systematic Review and Meta-Analysis of the Use of Serum Leucine-Rich Alpha-2 Glycoprotein to Assess Crohn’s Disease Activity
Muneyori Okita, MD, Keita Nakashima, Takeshi Yamamura, MD, PhD, Shigeyuki Matsui, PhD
doi : 10.1093/ibd/izad128
Assessing Progression of Biologic Therapies Based on Smoking Status in Patients With Crohn’s DiseaseÂ
Madeline Alizadeh, BS, Osman Ali, MD, MS, Raymond K Cross, MD, MSÂ
doi : 10.1093/ibd/izad131
Plasma Extracellular Vesicle LncRNA H19 as a Potential Diagnostic Biomarker for Inflammatory Bowel Diseases
Raheleh Heydari, MSc, Sara Fayazzadeh, PhD, Shabnam Shahrokh, MD, Faezeh Shekari, PhD, Faraneh Farsad, MD, Anna Meyfour, PhD
doi : 10.1093/ibd/izad219
Exploring Predictive Biomarkers of Relapse in Ulcerative Colitis: A Proteomics Approach
Arash Assadsangabi, MD, PhD, Caroline A Evans, PhD, Bernard M Corfe, PhD, Alan J Lobo, MD
doi : 10.1093/ibd/izad241
Dysregulated Immunity to Clostridioides difficile in IBD Patients Without a History of Recognized InfectionÂ
Laura Cook, PhD, May Q Wong, BSc, William D Rees, PhD, Alana Schick, PhD, Daniel J Lisko, MSc, Genelle R Lunken, PhD, Xiaojiao Wang, MSc, Hannah Peters, MSc, Laura Oliveira, MHA, Torey Lau, MD, Regan Mah, MD, Brian Bressler, MD, Megan K Levings, PhD, Theodore S Steiner, MD
doi : 10.1093/ibd/izad238
Safety and Monitoring of Inflammatory Bowel Disease Advanced Therapies
Shubha Bhat, PharmD, Benjamin Click, MD, Miguel Regueiro, MD
doi : 10.1093/ibd/izad120
Unveiling Colitis: A Journey through the Dextran Sodium Sulfate-induced ModelÂ
Chunhua Yang, PhD, Didier Merlin, PhD
doi : 10.1093/ibd/izad312
Lack of Seroconversion Following COVID-19 Vaccination Is an Independent Risk Factor for SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: Data from ESCAPE-IBD, an IG-IBD Study
Fabio Salvatore Macaluso, MD, Mariabeatrice Principi, MD, PhD, Federica Facciotti, PhD, Antonella Contaldo, MD, Alessia Todeschini, MD, Simone Saibeni, MD, Cristina Bezzio, MD, Fabiana Castiglione, MD, PhD, Olga Maria Nardone, MD, Rocco Spagnuolo, MD, Massimo Claudio Fantini, MD, PhD, Gaia Riguccio, MD, Simone Conforti, MD, Flavio Caprioli, MD, PhD, Chiara Viganò, MD, Carla Felice, MD, PhD, Gionata Fiorino, MD, PhD, Carmen Correale, PhD, Giorgia Bodini, MD, PhD, Monica Milla, MD, PhD, Giulia Scardino, MD, Marta Vernero, MD, Federico Desideri, MD, Fabrizio Bossa, MD, Maria Guerra, MD, Marco Ventimiglia, Angelo Casà , MD, Giuseppe Rizzo, MD, Ambrogio Orlando, MD, Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)
doi : 10.1093/ibd/izad118
Antibody, not Cellular, Immune Responses to SARS-CoV-2 Vaccination Outperform Infection in Inflammatory Bowel Disease Patients
Elizabeth González Cueto, MS, Matthew Edmans, PhD, Judith Wellens, MD, Ken Cadwell, PhD, Craig Thompson, PhD, Jack Satsangi, MD, Serre-Yu Wong, MD, PhD, ICARUS-IBD working group
doi : 10.1093/ibd/izad265
The Ileal Pouch-Anal Anastomosis: Identifying Structural Disorders
David M Schwartzberg, MD, Maia Kayal, MD, Edward L Barnes, MD, MPH
doi : 10.1093/ibd/izad320
Tofacitinib as a Rescue Therapy for Ulcerative Colitis in PregnancyÂ
Catherine Rowan, MB, BCH, BAO, MD, Fiona Yeaman, MBBS (Hons), MPHTM and BMedSc (Hons), Kenneth Ernest-Suarez, BSci (Med), MD, Marie-Louise Martin, BA, BScN, MN, ACNP, Remo Panaccione, MD, FRCPC, Tushar Shukla, MD, FRCPC, Matt Grossi, MD, FRCSC, Meghan Vlasschaert, MD, MSc, FRCPC, Kerri Novak, MD, MSc, FRCPC, Cynthia Seow, MBBS (Hons), MSc, FRACP
doi : 10.1093/ibd/izae076
Associations of Fish and Fish Oil Consumption With Incident Inflammatory Bowel Disease: A Population-Based Prospective Cohort Study
Xuanming Fan, MD, Yilong Liu, MD, Zixuan He, MD, Yu Bai, MD, PhD
doi : 10.1093/ibd/izae019
Methodological Standards When Reporting From National Databases
Hassam Ali, MD
doi : 10.1093/ibd/izae018
Ustekinumab and Vedolizumab Exposure Is Unaffected by Pharmacogenetic Determinants of Anti-TNFs Pharmacokinetics
Dahham Alsoud, MD, Bram Verstockt, MD, PhD, Séverine Vermeire, MD, PhD
doi : 10.1093/ibd/izae035
Correction to: Fungal Microbiota Composition in Inflammatory Bowel Disease Patients: Characterization in Different Phenotypes and Correlation With Clinical Activity and Disease CourseÂ
doi : 10.1093/ibd/izae070
